Drug-related adverse events may predict efficacy in sorafenib therapy for hepatocellular carcinoma. [electronic resource]
Producer: 20121011Description: 790-1 p. digitalISSN:- 1527-3350
No physical items for this record
Publication Type: Letter; Comment
There are no comments on this title.
Log in to your account to post a comment.